commentary
Enhancing Value of MRI: A Call for Action
Yoshimi Anzai MD, MPH,
Satoshi Minoshima MD, PhD,
Vivian S. Lee MD, PhD, MBA,
Corresponding Author
Yoshimi Anzai MD, MPH
Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah, USA
Address reprint requests to: Y.A., Professor of Radiology, University of Utah, 30N, 1900 E., Rm. 1A71, Salt Lake City, UT 84132. E-mail: [email protected]Search for more papers by this authorSatoshi Minoshima MD, PhD
Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah, USA
Search for more papers by this authorVivian S. Lee MD, PhD, MBA
Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah, USA
Search for more papers by this authorYoshimi Anzai MD, MPH,
Satoshi Minoshima MD, PhD,
Vivian S. Lee MD, PhD, MBA,
Corresponding Author
Yoshimi Anzai MD, MPH
Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah, USA
Address reprint requests to: Y.A., Professor of Radiology, University of Utah, 30N, 1900 E., Rm. 1A71, Salt Lake City, UT 84132. E-mail: [email protected]Search for more papers by this authorSatoshi Minoshima MD, PhD
Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah, USA
Search for more papers by this authorVivian S. Lee MD, PhD, MBA
Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah, USA
Search for more papers by this authorAbstract
As national healthcare spending has spiraled out of control, payment reform that moves from volume to value-based payment has been introduced as a practical solution. Under alternative value-based payment models, physicians and clinical teams must deliver the best care possible at a lower cost. Medical imaging has changed the way we diagnose disease, evaluate severity, assess treatment effects, and provide biological insights for the pathophysiology of many diseases. Over the past 50 years, imaging techniques have become increasingly advanced—from X-ray to computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and multi-modal imaging. Advanced imaging such as MRI has given clinicians remarkable insights into medical conditions and saved innumerable lives. Under the value proposition, however, we must ask if each imaging study changes treatment decisions, improves patient outcomes, and is cost-effective. Imaging research has been focused on developing new technologies and clinical applications to assess diagnostic accuracy. What is needed is the higher-level technology assessment. In this article we review why we need to demonstrate the value of MRI, how we define value, what strategies can enhance MR value through partnership with various stakeholders, and how imaging scientists can contribute to healthcare delivery in the future.
Level of Evidence: 5
Technical Efficacy: Stage 3
J. Magn. Reson. Imaging 2019;49:e40–e48.
References
- 1Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA 2018; 319: 1024–1039.
- 2Bauchner H, Fontanarosa PB. Health care spending in the United States compared with 10 other high-income countries: What Uwe Reinhardt might have said. JAMA 2018; 319: 990–992.
- 3Angrisano C, Farrell D, Kocher R, Laboissiere M, Parker S. Accounting for the cost of health care in the United States. New York: McKinsey & Co. 2017; 2018.
- 4Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA 2012; 307: 1513–1516.
- 5Emanuel EJ. The real cost of the US health care system. JAMA 2018; 319: 983–985.
- 6Tseng P, Kaplan RS, Richman BD, Shah MA, Schulman KA. Administrative costs associated with physician billing and insurance-related activities at an academic health care system. JAMA 2018; 319: 691–697.
- 7Lee VS, Blanchfield BB. Disentangling health care billing: For patients' physical and financial health. JAMA 2018; 319: 661–663.
- 8Hendee WR, Becker GJ, Borgstede JP, et al. Addressing overutilization in medical imaging. Radiology 2010; 257: 240–245.
- 9Lee VS. Annual oration: Driving value through imaging. Radiology 2017; 285: 3–11.
- 10Lee CI, Enzmann DR. Measuring radiology's value in time saved. JAm Coll Radiol 2012; 9: 713–717.
- 11Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harvard Business Review 2011; R9011B: 1–19.
- 12Porter ME. What is value in health care? N Engl J Med 2010; 363: 2477–2481.
- 13Burwell SM. Setting value-based payment goals—HHS efforts to improve U.S. health care. N Engl J Med 2015; 372: 897–899.
- 14Porter ME, Teisberg EO. Redefining health care: Creating value-based competition on results. Cambridge, MA: Harvard Business School Press; 2006.
- 15Dodoo MS, Duszak R Jr, Hughes DR. Trends in the utilization of medical imaging from 2003 to 2011: Clinical encounters offer a complementary patient-centered focus. JAm Coll Radiol 2013; 10: 507–512.
- 16Lee DW, Duszak R Jr, Hughes DR. Comparative analysis of Medicare spending for medical imaging: Sustained dramatic slowdown compared with other services. Am J Roentgenol 2013; 201: 1277–1282.
- 17Lehnert BE, Bree RL. Analysis of appropriateness of outpatient CT and MRI referred from primary care clinics at an academic medical center: How critical is the need for improved decision support? JAm Coll Radiol 2010; 7: 192–197.
- 18Smith-Bindman R, Miglioretti DL, Larson EB. Rising use of diagnostic medical imaging in a large integrated health system. Health Affairs 2008; 27: 1491–1502.
- 19Strother MK, Robert EC, Cobb JG, Pruthi S, Feurer ID. Reduction in the number and associated costs of unindicated dual-phase head CT examinations after a quality improvement initiative. Am J Roentgenol 2013; 201: 1049–1056.
- 20Huisa BN, Raman R, Ernstrom K, et al. Alberta stroke program early CT score (ASPECTS) in patients with wake-up stroke. JStroke Cerebrovasc Dis 2010; 19: 475–479.
- 21Alberts MJ, Ollenschleger MD, Nouh A. Dawn of a new era for stroke treatment: Implications of the DAWN study for acute stroke care and stroke systems of care. Circulation 2018 [Epub ahead of print].
- 22Lepore MR Jr, Sternbergh WC 3rd, Salartash K, Tonnessen B, Money SR. Influence of NASCET/ACAS trial eligibility on outcome after carotid endarterectomy. JVasc Surg 2001; 34: 581–586.
- 23Ferguson GG, Eliasziw M, Barr HW, et al. The North American symptomatic carotid endarterectomy trial: Surgical results in 1415 patients. Stroke 1999; 30: 1751–1758.
- 24Simonetti G, Bozzao A, Floris R, Silvestrini M. Non-invasive assessment of neck-vessel pathology. Eur Radiol 1998; 8: 691–697.
- 25Tardivon AA, Athanasiou A, Thibault F, El Khoury C. Breast imaging and reporting data system (BIRADS): Magnetic resonance imaging. Eur J Radiol 2007; 61: 212–215.
- 26Kawamoto K, Martin CJ, Williams K, et al. Value driven outcomes (VDO): A pragmatic, modular, and extensible software framework for understanding and improving health care costs and outcomes. JAm Med Informat Assoc 2015; 22: 223–235.
- 27Lee VS, Kawamoto K, Hess R, et al. Implementation of a value-driven outcomes program to identify high variability in clinical costs and outcomes and association with reduced cost and improved quality. JAMA 2016; 316: 1061–1072.
- 28Kaplan RS. Improving value with TDABC. Healthcare Financial Manage 2014; 68: 76–83.
- 29French KE, Guzman AB, Rubio AC, Frenzel JC, Feeley TW. Value based care and bundled payments: Anesthesia care costs for outpatient oncology surgery using time-driven activity-based costing. Healthcare 2016; 4: 173–180.
- 30Nisenbaum HL, Birnbaum BA, Myers MM, Grossman RI, Gefter WB, Langlotz CP. The costs of CT procedures in an academic radiology department determined by an activity-based costing (ABC) method. JComput Assist Tomogr 2000; 24: 813–823.
- 31McLaughlin N, Burke MA, Setlur NP, et al. Time-driven activity-based costing: A driver for provider engagement in costing activities and redesign initiatives. Neurosurg Focus 2014; 37: E3.
- 32DiGioia AM 3rd, Greenhouse PK, Giarrusso ML, Kress JM. Determining the true cost to deliver total hip and knee arthroplasty over the full cycle of care: Preparing for bundling and reference-based pricing. JArthropl 2016; 31: 1–6.
- 33Anzai Y, Heilbrun ME, Haas D, et al. Dissecting costs of CT study: Application of TDABC (time-driven activity-based costing) in a tertiary academic center. Acad Radiol 2017; 24: 200–208.
- 34Mandigo M, O'Neill K, Mistry B, et al. A time-driven activity-based costing model to improve health-care resource use in Mirebalais, Haiti. Lancet 2015; 385(Suppl 2): S22.
- 35Akhavan S, Ward L, Bozic KJ. Time-driven activity-based costing more accurately reflects costs in arthroplasty surgery. Clin Orthop Relat Res 2016; 474: 8–15.
- 36McCullough BJ, Johnson GR, Martin BI, Jarvik JG. Lumbar MR imaging and reporting epidemiology: Do epidemiologic data in reports affect clinical management? Radiology 2012; 262: 941–946.
- 37Marino MA, Helbich T, Baltzer P, Pinker-Domenig K. Multiparametric MRI of the breast: A review. JMagn Reson Imaging 2018; 47: 301–315.
- 38Hectors SJ, Wagner M, Besa C, et al. Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI? JMagn Reson Imaging 2016; 44: 856–864.
- 39Rigual D, Rove M, Robison Z, et al. Emergency department CT expediency: A time reduction by redesign. JAm Coll Radiol 2016; 13: 178–181.
- 40Sanchez Y, Yun BJ, Prabhakar AM, et al. Magnetic resonance imaging utilization in an emergency department observation unit. West J Emerg Med 2017; 18: 780–784.
- 41Erly WK, Tran M, Dillon RC, Krupinski E. Impact of hindsight bias on interpretation of nonenhanced computed tomographic head scans for acute stroke. JComput Assist Tomogr 2010; 34: 229–232.
- 42Quenardelle V, Lauer-Ober V, Zinchenko I, et al. Stroke mimics in a stroke care pathway based on MRI screening. Cerebrovasc Dis 2016; 42: 205–212.
- 43Brook RH. The role of physicians in controlling medical care costs and reducing waste. JAMA 2011; 306: 650–651.
- 44Young NP, Elrashidi MY, McKie PM, Ebbert JO. Neuroimaging utilization and findings in headache outpatients: Significance of red and yellow flags. Cephalalgia 2018: 333102418758282.
- 45Levin DC, Rao VM. Reducing inappropriate use of diagnostic imaging through the choosing wisely initiative. JAm Coll Radiol 2017; 14: 1245–1252.
- 46Jung HY, Vest JR, Unruh MA, Kern LM, Kaushal R. Use of health information exchange and repeat imaging costs. JAm Coll Radiol 2015; 12: 1364–1370.
- 47Lee VS. Science to practice: Can MR imaging replace liver biopsy for the diagnosis of early fibrosis? Radiology 2006; 239: 309–310.
- 48Taouli B, Beer AJ, Chenevert T, et al. Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshop. JMagn Reson Imaging 2016; 44: 521–540.
- 49Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018; 378: 708–718.
- 50Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018; 378: 11–21.
- 51Jovin TG, Saver JL, Ribo M, et al. Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with TREVO (DAWN) trial methods. Int J Stroke 2017; 12: 641–652.
- 52Shuhendler AJ, Ye D, Brewer KD, et al. Molecular magnetic resonance imaging of tumor response to therapy. Sci Rep 2015; 5: 14759.
- 53Haris M, Bagga P, Hariharan H, McGettigan-Croce B, Johnson LA, Reddy R. Molecular imaging biomarkers for cell-based immunotherapies. JTransl Med 2017; 15: 140.
- 54Kruger SJ, Nagle SK, Couch MJ, Ohno Y, Albert M, Fain SB. Functional imaging of the lungs with gas agents. JMagn Reson Imaging 2016; 43: 295–315.
- 55Prinsen H, de Graaf RA, Mason GF, Pelletier D, Juchem C. Reproducibility measurement of glutathione, GABA, and glutamate: Towards in vivo neurochemical profiling of multiple sclerosis with MR spectroscopy at 7T. JMagn Reson Imaging 2017; 45: 187–198.
- 56Grewal M, Dabas A, Saharan S, Barker PB, Edden RA, Mandal PK. GABA quantitation using MEGA-PRESS: Regional and hemispheric differences. JMagn Reson Imaging 2016; 44: 1619–1623.
- 57Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making 1991; 11: 88–94.
- 58Thornbury JR, Fryback DG. Technology assessment—An American view. Eur J Radiol 1992; 14: 147–156.
- 59Levin DC, Parker L, Rao VM. Recent trends in imaging use in hospital settings: Implications for future planning. JAm Coll Radiol 2017; 14: 331–336.
- 60Levin DC, Parker L, Rao VM. The recent losses in Medicare imaging revenues experienced by radiologists, cardiologists, and other physicians. JAm Coll Radiol 2017; 14: 1007–1012.
- 61Bender CE, Parikh JR, Arleo EK, Bluth E. The radiologist and depression. JAm Coll Radiol 2016; 13: 863–867.
- 62Chew FS, Mulcahy MJ, Porrino JA, Mulcahy H, Relyea-Chew A. Prevalence of burnout among musculoskeletal radiologists. Skeletal Radiol 2017; 46: 497–506.
- 63Harolds JA, Parikh JR, Bluth EI, Dutton SC, Recht MP. Burnout of radiologists: Frequency, risk factors, and remedies: A report of the ACR commission on human resources. JAm Coll Radiol 2016; 13: 411–416.
Citing Literature
